Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating. | MicrobiomeTrials← Back to trialsNCT06772064
Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating.
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-04-15Est. Completion: 2025-12-01
Enrollment target: 115 participants Locations- Qilu Hospital of Shandong University, Jinan, Shandong, China
Other microbiome trials you might be interested in
Low Grade AstrocytomaLow Grade GliomaMetastatic Low Grade AstrocytomaMetastatic Low Grade GliomaWHO Grade 1 GliomaWHO Grade 2 Glioma
This phase III trial compares the effect of selumetinib versus the standard of care treatment with carboplatin and vincr…
Birmingham, United StatesEst. completion Dec 31, 2030
Malignant Glioma
This phase I/II trial tests the safety, side effects, and best dose of selinexor given in combination with standard radi…
Birmingham, United StatesEst. completion Jun 30, 2027
Irritable Bowel Syndrome (IBS)Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
The goal of this clinical trial is to learn if an herbal supplement called Biocidin REMOVE can clear small intestinal ba…
Baltimore, United StatesEst. completion Dec 31, 2027